Oscar Health (OSCR)

Generated: September 19, 2026

Yellow Dot

Statistics

Metric	Value
Last Close	$32.12
Blended Price Target	38.11
Blended Margin of Safety	18.7% Undervalued
Rule of 40 (Next)	188.3%
Rule of 40 (Current)	236.4%
FCF-ROIC	176.4%
Sales Growth Next Year	12.0%
Sales Growth Current Year	60.0%
Sales 3-Year Avg	44.6%
Industry	Healthcare Plans

Analysis

Oscar Health today looks like a much more durable and disciplined insurer than its early-stage reputation suggests. The business is anchored in individual and small-group health insurance sold on and off Affordable Care Act (ACA) exchanges, complemented by technology-enabled administration services, which together create a largely recurring revenue base tied to annual memberships and premiums.^[5]^[11] Revenue growth has been strong, with Q2 2026 total revenue around $4.9 billion, up roughly 70% year over year, and management has responded by raising full-year 2026 earnings-from-operations guidance, signaling confidence in the underlying franchise.^[5]^[12]^[15]

The predictability of premiums, combined with improving medical loss ratio (MLR) and SG&A efficiency, suggests that Oscar’s growth is increasingly supported by operational discipline rather than just member expansion.^[11] The moat is still emerging rather than fully entrenched: Oscar competes against large national carriers but differentiates through consumer-friendly product design, data-driven care management, and proprietary technology that lowers administrative costs and supports more personalized member engagement.^[11] Founder-led leadership, record profitability in the first half of 2026, and a willingness to reset strategy and raise guidance when performance warrants it point to a management team that has matured, making Oscar a higher-quality but still execution-sensitive business.^[9]^[11]^[12]^[15]

What the Company Does

Oscar Health is a technology-driven health insurance company focused on delivering ACA-compliant individual and family plans, small-group coverage, and related services through a consumer-centric, digitally enabled platform. It makes money primarily by collecting insurance premiums from members and managing medical costs, retaining the spread between premiums and claims plus any fee-based income from services provided to other partners.^[5]^[11]

Within that model, Oscar’s revenue comes largely from health insurance premiums across its exchange and small-group products, supplemented by administrative and technology fees from arrangements where it provides infrastructure or care management capabilities to other entities.^[5]^[11] Public disclosures in the last six months emphasize the dominance of core insurance revenue and do not break out recent segment percentages, so the mix is best understood qualitatively as insurance-first with a growing, but still secondary, technology and services layer.^[5]^[9]^[11]

Revenue Recurrence & Predictability

Oscar’s revenue base is primarily contractual and recurring, driven by annual and semi-annual health insurance policies that renew on the ACA calendar cycle and employer benefit cycles. Members typically commit for coverage periods of a year, and premiums are paid monthly, creating a steady inflow that is more predictable than transactional or project-based businesses.^[5]^[11] As long as members remain enrolled and regulators maintain the current ACA framework, a substantial portion of revenue can be forecast based on membership and pricing.

Predictability, however, depends on both membership retention and the accuracy of medical cost assumptions. While premiums are recurring, profitability is sensitive to medical loss ratio and utilization trends, which can shift with regulatory changes, macroeconomic conditions, and health events. Oscar’s Q2 2026 results highlight significant year-over-year improvement in MLR and SG&A ratios, suggesting better control over costs and a more reliable relationship between premiums and earnings, though this stability must be proven across multiple cycles.^[11]

Revenue Growth Durability

Oscar’s growth prospects are tied to the still-evolving ACA individual market, small-group coverage, and the potential to expand into adjacent administrative and technology services. Management reported 70% year-over-year revenue growth in Q2 2026, driven by higher membership and rate increases, and raised full-year 2026 earnings guidance, implying confidence in sustained momentum at least over the near term.^[5]^[9]^[12]^[15] The total addressable market remains significant given ongoing enrollment in ACA exchanges and persistent demand for more accessible, digital-first health coverage.

Longer-term durability depends on Oscar’s ability to deepen penetration without sacrificing underwriting discipline, maintain competitive pricing as medical costs evolve, and scale its technology platform for partner use. Structural tailwinds include continued ACA support, consumer preference for modern digital experiences, and employer interest in lower-cost, data-driven plans. Headwinds include intense competition from scaled incumbents, potential policy shifts, and the inherent cyclicality of insurance margins, making sustained above-market growth plausible but contingent on execution and regulatory stability.^[5]^[9]^[11]

Economic Moat

Oscar’s moat rests on technology, brand, and data-driven operations rather than on sheer scale. The company positions itself as a “healthcare technology” firm, using proprietary systems to manage enrollment, claims, and care coordination, which management credits for the sharp improvement in SG&A expense ratios to record lows in Q2 2026.^[11] These efficiencies can translate into cost advantages per member and faster product iteration, differentiating Oscar from more traditional carriers that rely on legacy systems.^[11]

Intangible assets include a consumer-friendly brand, digital-native user experience, and data assets from managing large volumes of member interactions and medical claims. However, network effects and switching costs remain moderate: members can change plans annually on exchanges, and employers regularly review carriers. The moat appears to be widening modestly as technology-led efficiencies and care management capabilities scale, but it is still vulnerable to imitation by larger insurers and subject to regulatory constraints on product differentiation.^[5]^[9]^[11]

Management & Leadership

Oscar Health is founder-led. Co-founder Mario Schlosser has long been associated with the company’s vision of combining technology and health insurance, though day-to-day leadership has evolved over time as Oscar moved from startup to public company; recent disclosures highlight a seasoned executive team guiding the firm through its current profitable phase.^[11] The Q2 2026 earnings call underscores management’s focus on disciplined growth, improved margins, and raising guidance only after delivering record profitability.^[9]^[11]^[12]^[15]

Insider ownership has historically been meaningful due to founder and early investor stakes, but recent filings in the last six months do not prominently disclose updated percentages in a way suitable for precise citation here. Capital allocation decisions have centered on reinvesting in technology, tightening underwriting standards, and prioritizing profitability over pure membership growth, as evidenced by the strong improvement in earnings from operations and margin metrics in the first half of 2026.^[5]^[9]^[11]

Key Risks

A central risk is regulatory and policy exposure. Oscar’s core business is intertwined with ACA exchanges, subsidies, and minimum coverage standards; significant changes to federal or state healthcare policy, funding, or regulations could affect membership levels, pricing flexibility, and required benefits. This dependence on a politically sensitive framework makes long-term planning more complex and increases the importance of regulatory monitoring and advocacy.^[5]^[11]

Competitive risk is also material. Oscar competes against large national insurers and well-capitalized regional plans that have greater scale, broader provider networks, and more negotiating leverage with hospitals and physicians. These incumbents can pressure margins through aggressive pricing or targeted product launches in Oscar’s key markets. While Oscar differentiates via technology and user experience, these advantages can be narrowed if rivals upgrade their digital capabilities or match consumer-friendly features.^[5]^[9]^[11]

Finally, execution and underwriting risk remains significant. The improved MLR and profitability in Q2 2026 reflect better cost management, but insurance businesses are inherently exposed to fluctuations in medical utilization, unexpected health events, and reserve adequacy. Mispricing plans, underestimating utilization, or encountering adverse selection could quickly erode margins and force corrective actions. As Oscar scales, maintaining data quality, risk models, and operational controls across more markets and products is critical to sustaining the progress seen in recent quarters.^[5]^[9]^[11]

Sources

Featured in GreenDot Stocks Analysis

GreenDot Stocks Screen Update — Week of September 19, 2026 September 19, 2026